1. Press OW . Emerging immunotherapies for non-Hodgkin lymphoma: the tortoise approaches the finish line Ann Intern Med 2000 132: 916–918
2. Denardo SJ, Kroger LA, Denardo GL . A new era for radiolabeled antibodies in cancer Curr Opin Immunol, 1999 11: 563–569
3. Kaminski MS, Gribbin T, Estes J, Ross CW, Regan D, Zasadny K, Tamminen J, Kison P, Tuck M, Fisher S . I-131 anti-B1 antibody for previously untreated follicular lymphoma (FL): clinical and molecular remissions Proc Am Soc Clin Oncol 1998 17: 2
4. Knox SJ, Goris ML, Trisler K, Negrin R, Davis T, Liles TM, Grillo-Lopez A, Chinn P, Varns C, Ning SC, Fowler S, Deb N, Becker M, Marquez C, Levy R . Yttrium-90-labeled anti-CD20 monoclonal antibody therapy of recurrent B-cell lymphoma Clin Cancer Res 1996 2: 457–470
5. DeNardo SJ, Denardo GI, Goldstein DS, Kroger LA, Lamborn KR, Levey NB, McGahan JP, Salako Q, Shen S, Lewis JP . Maximum tolerated dose, toxicity, and efficacy of I-131-Lym-1 antibody for fractionated radioimmunotherapy of non-Hodgkin's lymphoma J Clin Oncol 1998 16: 3246–3256